Gregory Engel
Overview
Explore the profile of Gregory Engel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Friedman P, Murgatroyd F, Boersma L, Manlucu J, Knight B, Clementy N, et al.
Circulation
. 2024 Sep;
151(4):322-332.
PMID: 39327797
Background: Substernal lead placement of the extravascular implantable cardioverter defibrillator (EV ICD) permits both defibrillation at thresholds similar to those seen with transvenous implantable cardioverter defibrillators and effective anti-tachycardia pacing...
2.
Winkle R, Hardwin Mead R, Engel G, Salcedo J, Brodt C, Barberini P, et al.
J Cardiovasc Electrophysiol
. 2024 Mar;
35(5):984-993.
PMID: 38486082
Introduction: Little is known about very early atrial fibrillation (AF) ablation after first AF detection. Methods: We evaluated patients with AF ablation <4 months from newly diagnosed paroxysmal AF (NEWPaAF)...
3.
Wong K, Schricker A, Nerlekar R, Feng Z, Sudat S, Cook K, et al.
JACC Clin Electrophysiol
. 2023 Aug;
9(10):2166-2168.
PMID: 37589645
No abstract available.
4.
Winkle R, Hardwin Mead R, Engel G, Salcedo J, Brodt C, Barberini P, et al.
Heart Rhythm
. 2023 Feb;
20(5):680-688.
PMID: 36764350
Background: Little is known about the very long term durability of atrial fibrillation (AF) ablation. Objective: The purpose of this study was to evaluate very long term AF ablation outcomes....
5.
Thompson A, Atwater B, Boersma L, Crozier I, Engel G, Friedman P, et al.
J Cardiovasc Electrophysiol
. 2022 Apr;
33(6):1085-1095.
PMID: 35478368
Introduction: The extravascular implantable cardioverter-defibrillato (EV ICD) system with substernal lead placement is a novel nontransvenous alternative to current commercially available ICD systems. The EV ICD provides defibrillation and pacing...
6.
Boyalla V, Jarman J, Markides V, Hussain W, Wong T, Hardwin Mead R, et al.
Open Heart
. 2021 Aug;
8(2).
PMID: 34348972
Background: The clinical effectiveness of ablating non-paroxysmal atrial fibrillation (non-PAF) relies on proper patient selection. We developed and validated a scoring system to predict non-PAF ablation outcomes. Methods: Data on...
7.
Winkle R, Hardwin Mead R, Engel G, Kong M, Salcedo J, Brodt C, et al.
Heart Rhythm
. 2020 Apr;
17(8):1223-1231.
PMID: 32272229
Background: Little is known about the long-term outcomes and predictors of success of high-power, short-duration (HPSD) contact force (CF) atrial fibrillation (AF) ablations. Objective: The purpose of this study was...
8.
Engel G, Rockson S
Am J Med Sci
. 2020 Feb;
359(2):73-78.
PMID: 32039768
Background: Prevailing hospital practice dictates a protracted phase of observation for patients with chest pain to establish or exclude the diagnosis of myocardial infarction. Early diagnosis of acute myocardial infarction...
9.
Winkle R, Mohanty S, Patrawala R, Hardwin Mead R, Kong M, Engel G, et al.
Heart Rhythm
. 2019 Feb;
16(2):165-169.
PMID: 30712645
Background: Many centers use radiofrequency (RF) energy at 25-35 W for 30-60 seconds. There is a safety concern about using higher power, especially on the posterior wall. Objective: The purpose...
10.
Winkle R, Fleming W, Hardwin Mead R, Engel G, Kong M, Salcedo J, et al.
J Interv Card Electrophysiol
. 2019 Feb;
55(2):183-189.
PMID: 30706254
Purpose: To compare findings in patients undergoing atrial fibrillation(AF) and/or atrial flutter(AFl) ablation after failed cut and sew (CS) vs. non-cut and sew (NCS) surgical maze. Methods: We compared 10...